Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The RVO group also had a higher prevalence of DM, lower prevalence of hyperlipidemia and polycythemia, and lower intakes of Zn, β-carotene, vitamin C, vitamin D, and ω-3 fatty acids; these differences were not significant.

Source: 3.1. Baseline Characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Methods: This cross-sectional study included participants of the Korean National Health and Nutrition Examination Survey 2017 to 2021 aged ≥19 years (n = 16,358).

Source: Abstract.

Only data of participants aged ≥19 years were included for analysis.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis

Cross-sectional study · Nutrients · 2025

Original publication title

Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis

Jiwoo Kim; Min Kim; Christopher Seungkyu Lee; Eun Young Choi

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Retinal vein occlusion (RVO) is a major cause of vision loss globally. Although magnesium (Mg) is crucial for vascular health, its association with RVO risk is unknown. Thus, we aimed to further examine this association.

Methods:

This cross-sectional study included participants of the Korean National Health and Nutrition Examination Survey 2017 to 2021 aged ≥19 years (n = 16,358). RVO diagnosis was based on fundus imaging or was self-reported. Based on their daily Mg intake, we categorized participants into low (<120 mg), intermediate (men: 120 to 300 mg; women: 120 to 400 mg), and sufficient (men: ≥300 mg; women: ≥400 mg) intake groups and compared their characteristics across groups.

Results:

RVO prevalence was 0.7%. Compared to the non-RVO group, the RVO group was characterized by older individuals, fewer current alcohol consumers, a higher prevalence of hypertension and chronic kidney disease, and a lower intake of fiber, iron, calcium, vitamin E, and Mg. After full adjustment, sufficient Mg intake was significantly associated with a 64% reduced risk of RVO (odds ratio [OR] 0.36, 95% confidence interval [CI] 0.18 to 0.71, p = 0.003). This association was particularly notable among individuals aged 19 to 59 years (OR 0.18, 95% CI 0.04 to 0.82, p = 0.027), those with hypertension (OR 0.29, 95% CI 0.13 to 0.67, p = 0.003), and those without glaucoma (OR 0.33, 95% CI 0.15 to 0.71, p = 0.004).

Conclusions:

Sufficient Mg intake may reduce RVO risk among adults aged <60 years, individuals with hypertension, and those without glaucoma. Further research should validate the benefits of Mg supplementation in preventing RVO.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Retinal vein occlusion (RVO) is a major cause of vision loss globally. Although magnesium (Mg) is crucial for vascular health, its association with RVO risk is unknown. Thus, we aimed to further examine this association.

Source: Background/Objectives:

Abstract: Results

RVO prevalence was 0.7%. Compared to the non-RVO group, the RVO group was characterized by older individuals, fewer current alcohol consumers, a higher prevalence of hypertension and chronic kidney disease, and a lower intake of fiber, iron, calcium, vitamin E, and Mg. After full adjustment, sufficient Mg intake was significantly associated with a 64% reduced risk of RVO (odds ratio [OR] 0.36, 95% confidence interval [CI] 0.18 to 0.71, p = 0.003). This association was particularly notable among individuals aged 19 to 59 years (OR 0.18, 95% CI 0.04 to 0.82, p = 0.027), those with hypertension (OR 0.29, 95% CI 0.13 to 0.67, p = 0.003), and those without glaucoma (OR 0.33, 95% CI 0.15 to 0.71, p = 0.004).

Source: Results:

Abstract: Conclusions

Sufficient Mg intake may reduce RVO risk among adults aged <60 years, individuals with hypertension, and those without glaucoma. Further research should validate the benefits of Mg supplementation in preventing RVO.

Source: Conclusions:
Authors’ abstract

Background/Objectives:

Retinal vein occlusion (RVO) is a major cause of vision loss globally. Although magnesium (Mg) is crucial for vascular health, its association with RVO risk is unknown. Thus, we aimed to further examine this association.

Methods:

This cross-sectional study included participants of the Korean National Health and Nutrition Examination Survey 2017 to 2021 aged ≥19 years (n = 16,358). RVO diagnosis was based on fundus imaging or was self-reported. Based on their daily Mg intake, we categorized participants into low (<120 mg), intermediate (men: 120 to 300 mg; women: 120 to 400 mg), and sufficient (men: ≥300 mg; women: ≥400 mg) intake groups and compared their characteristics across groups.

Results:

RVO prevalence was 0.7%. Compared to the non-RVO group, the RVO group was characterized by older individuals, fewer current alcohol consumers, a higher prevalence of hypertension and chronic kidney disease, and a lower intake of fiber, iron, calcium, vitamin E, and Mg. After full adjustment, sufficient Mg intake was significantly associated with a 64% reduced risk of RVO (odds ratio [OR] 0.36, 95% confidence interval [CI] 0.18 to 0.71, p = 0.003). This association was particularly notable among individuals aged 19 to 59 years (OR 0.18, 95% CI 0.04 to 0.82, p = 0.027), those with hypertension (OR 0.29, 95% CI 0.13 to 0.67, p = 0.003), and those without glaucoma (OR 0.33, 95% CI 0.15 to 0.71, p = 0.004).

Conclusions:

Sufficient Mg intake may reduce RVO risk among adults aged <60 years, individuals with hypertension, and those without glaucoma. Further research should validate the benefits of Mg supplementation in preventing RVO.

Publication and source details

Original title: Sufficient Magnesium Intake Reduces Retinal Vein Occlusion Risk: National Health and Nutrition Examination Survey Analysis

Jiwoo Kim; Min Kim; Christopher Seungkyu Lee; Eun Young Choi

Nutrients · 2025

* Correspondence: eychoi@yuhs.ac; Tel.: +82-2-2019-3441© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:52:13.563630+00:00

DOI: 10.3390/nu17071285 · PMC11990526